Clinical trial
Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute
NCT02036489 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute
- Lead sponsor
- PETHEMA Foundation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- December 1, 2019
- Enrollment
- 107 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphobkastic leukemia